• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Larger Trial Needed to Confirm Restrictive versus Liberal Blood Transfusion Policies for Acute Upper Gastrointestinal Bleeding

July 24, 2015

Bags of donated blood, close-up

Several large, randomized trials revealed that restrictive transfusion policies are safe for critical care patients and patients who have had hip surgery. However, data have been unclear for patients with cardiovascular disease.

In a pragmatic, open-labeled cluster randomized feasibility trial, researchers randomly assigned six United Kingdom hospitals to either a restrictive red blood cell (RBC) transfusion policy (hemoglobin < 80 g/L) or liberal (hemoglobin < 100 g/L) transfusions for acute upper gastrointestinal bleeding patients. Over six months, 403 patients at three hospitals received treatment with the restrictive policy, and 533 patients at three other hospitals received liberal transfusions. Although protocol adherence was higher in the restrictive group (96% vs 83%, p=0.005), no significant differences in clinical outcomes were observed. Fewer patients received RBCs and fewer units were transfused in the restrictive group, though differences were not significant. Larger randomized trials, including cluster trials, are needed to evaluate the safety of restrictive transfusion policies in patients with acute upper gastrointestinal bleeding.

Reference

1. Jairath V, Kahan BC, Gray A, Dore CJ, Mora A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Le Jeune I, Darwent M, Church N, Reckless I, Hodge R, Dyer C, Meredith S, Llewelyn C, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015 Jul 11;386(9989):137-44.

 

Filed Under

  • News
  • RBC Transfusion

Recommended

  • Whole Blood Derived Platelet vs. Apheresis Platelets

  • Twelve Month Donor Deferral for MSM May Not Increase Risk of Transfusion-Transmitted HIV

  • Low Alloimmunization Risk if No Antibodies Formed during First 20 RBC Transfused Units

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley